DIA is Proud to Announce the DIA 2025 Keynote Speakers
We are thrilled to unveil the DIA2025 esteemed keynote speakers at our Opening Plenary: From Personal Journeys to Global Solutions – Collaborating for Innovation and Patient Impact:
Jimi Olaghere | CasGevy Recipient
Jimi Olaghere is a CasGevy recipient who has developed a keen interest in the advancements of Cell and Gene therapies, since his transformative participation in the groundbreaking clinical trial. He is passionate about the positive impact these therapies can have on patients in need and has become a staunch advocate for increased accessibility of gene therapies for SCD patients worldwide.
Doug Melton, Ph.D. | Research Scholar at Vertex Pharmaceuticals
Dr. Melton is a distinguished research fellow at Vertex Pharmaceuticals where initial studies of people with type 1 diabetes who have received stem cell-derived islet cells (SC-islets) transplanted together with immunosuppressive drugs have shown promising results. Previously he served as the Director of the JDRF Center of Excellence in New England, a research collaboration with investigators (past and present) from Harvard and UMass Chan Medical Schools, The Jackson Laboratory, Joslin Diabetes Center, the Dana Farber Cancer Institute, and Boston Children’s Hospital. The Center is currently led by David Harlan, MD, co-director of the UMass Chan DCOE.